博卡拉顿，佛罗里达州，2026年10月14日，财经新闻合作将INmune Bio的临床研究与QCi的Dirac-3S量子优化机器相结合，以识别XPro的潜在新治疗适应症和生物标志物。
Boca Raton, Florida, October 14th, 2026, Financewire Collaboration combines INmune Bio’s clinical research with QCi’s Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro.
此次初步合作标志着QCi在制药和生物技术市场的首个商业客户，扩展了量子计算在药物开发中的应用。INmune Bio Inc.
Initial engagement marks QCi’s first commercial customer in pharmaceutical and biotechnology markets, expanding the application of quantum computing to drug development. INmune Bio Inc.